cardiac imaging

Global point-of-care diagnostics market reaches $58.76B in 2026, growing 10% annually toward $114.65B by 2035, driven by five companies revolutionizing decentralized healthcare delivery.

Medtech giants aggressively acquiring AI diagnostic platforms as hospital adoption surges. $2.20B market projected by 2026 with 34.8% growth through 2033.

U.S. cardiovascular devices market projected to nearly double to $41.29B by 2032, driven by aging demographics and AI-powered tools.

Healthcare pivots toward outpatient services as AI diagnostics and remote monitoring technologies gain traction. Multiple medtech firms advance innovative solutions addressing cost and accessibility.

Five AI companies advance decentralized cardiac diagnostics through partnerships expanding access to remote communities and strengthening clinical evidence bases.

HeartFlow CMO Rogers Campbell sold $1.66M in shares via pre-arranged plan while company guides 2026 revenue to $218–$222M, maintaining strong growth momentum despite current unprofitability.